Picard Medical Files 8-K on Financial Results, Exhibits
Ticker: PMI · Form: 8-K · Filed: Mar 25, 2026 · CIK: 0002030617
Complexity: simple
Sentiment: neutral
Topics: earnings, financial-condition, 8-K, corporate-filing
TL;DR
**Picard Medical just dropped an 8-K with their latest financial results, so check it for performance updates.**
AI Summary
Picard Medical, Inc. filed an 8-K on March 25, 2026, disclosing its results of operations and financial condition under Item 2.02. This filing also included financial statements and exhibits under Item 9.01, specifically Exhibit 99.1. This matters to investors because it provides the latest financial performance update, which can influence stock valuation and future investment decisions for Picard Medical, Inc. (CIK: 0002030617).
Why It Matters
This filing provides crucial, up-to-date financial information, allowing investors to assess Picard Medical's current health and make informed decisions about buying, holding, or selling its stock.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial results, which is standard for public companies and generally not a high-risk event.
Analyst Insight
A smart investor would review the full text of Exhibit 99.1 and the details under Item 2.02 to understand the specific financial results and operational conditions reported by Picard Medical, Inc. before making any investment decisions.
Key Players & Entities
- Picard Medical, Inc. (company) — the filer of the 8-K
- 0002030617 (company) — CIK of Picard Medical, Inc.
- 2026-03-25 (date) — filing date and period of report
FAQ
What specific items were reported in Picard Medical, Inc.'s 8-K filing on March 25, 2026?
The 8-K filing by Picard Medical, Inc. on March 25, 2026, reported 'Results of Operations and Financial Condition' under Item 2.02 and 'Financial Statements and Exhibits' under Item 9.01.
What is the accession number for this particular 8-K filing by Picard Medical, Inc.?
The SEC accession number for this 8-K filing is 0001829126-26-002663.
What is the CIK (Central Index Key) for Picard Medical, Inc.?
The CIK for Picard Medical, Inc. is 0002030617.
What type of document was included as Exhibit 99.1 in this 8-K filing?
Exhibit 99.1 in this 8-K filing was identified as 'picardmedical_ex99-1.htm' with a document type of EX-99.1.
What is the business address listed for Picard Medical, Inc. in this filing?
The business address listed for Picard Medical, Inc. is 1992 E. SILVERLAKE RD., TUCSON AZ 85713.
Filing Stats: 514 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2026-03-25 07:10:31
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share PMI The NYSE American, LL
Filing Documents
- picardmedical_8k.htm (8-K) — 27KB
- picardmedical_ex99-1.htm (EX-99.1) — 32KB
- 0001829126-26-002663.txt ( ) — 224KB
- pmi-20260325.xsd (EX-101.SCH) — 3KB
- pmi-20260325_lab.xml (EX-101.LAB) — 33KB
- pmi-20260325_pre.xml (EX-101.PRE) — 22KB
- picardmedical_8k_htm.xml (XML) — 3KB
02
Item 2.02. Results of Operations and Financial Condition. On March 25, 2026, Picard Medical, Inc. (the "Company") issued a press release announcing the Company's financial and operating results for the fiscal year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 and incorporated by reference herein. The information in this report and the exhibits attached hereto shall not be deemed to be "filed" for purposes of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.
01
Item 9.01. Financial (d) Exhibits The following exhibits are being furnished herewith: Exhibit No. Description 99.1 Picard Medical, Inc. Press Release dated March 25, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Picard Medical, Inc. By: /s/ Patrick NJ Schnegelsberg Name: Patrick NJ Schnegelsberg Title: Chief Executive Officer Dated: March 25, 2026 2